Home > Analytics > RAINBOW CHILDRENS MEDICARE

RAINBOW CHILDRENS MEDICARE
Intrinsic Value | Fundamental Analysis

BOM : 543524     NSE : RAINBOW    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : NA
Apr 19,2024
Price(EOD): ₹ 1,303.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Hospital & Healthcare Services
MCap: ₹ 13,228.50 Cr
Value of ₹ 1 Lac invested in RAINBOW CHILDRENS MEDICARE
on May 10,2022 (price: ₹ 450.10)

₹ 1 L

₹ 2.90 L

1W : 6.7% 1M : -2% 1Y : 68.5%
COMMUNITY POLL
for RAINBOW CHILDRENS MEDICARE
Please provide your vote to see the results
RAINBOW CHILDRENS MEDICARE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
RAINBOW CHILDRENS MEDICARE 6.7% -2% 68.5%
APOLLO HOSPITALS ENTERPRISE 3.4% -6.6% 49%
MAX HEALTHCARE INSTITUTE 5.7% -8.7% 59.1%
GLOBAL HEALTH 6.7% -13.1% 164.4%
FORTIS HEALTHCARE 2.6% -6.4% 59.4%
NARAYANA HRUDAYALAYA 2% -9.6% 59.5%
ASTER DM HEALTHCARE 1.9% -6.1% 86.2%
DR LAL PATHLABS 12.9% -7.3% 19.6%
KRISHNA INSTITUTE OF MEDICAL SCIENCES 3.3% -8.3% 51.4%

FUNDAMENTAL ANALYSIS OF RAINBOW CHILDRENS MEDICARE

 
Fundamentals Score
[ Q(TTM): Dec2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 RAINBOW is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF RAINBOW CHILDRENS MEDICARE

 
Valuation Score
[As on : Apr 19,2024 ]

Ratio Consolidated
P/E
P/B
P/S
59.84
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 221.09 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

12.48
P/B Calculated based on Book Value of Rs 1,059.91 Cr
[Latest Year - Mar2023 - Consolidated Results ]

10.39
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,272.76 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 12% undervalued companies ! Discover More →

FAIR VALUE OF RAINBOW CHILDRENS MEDICARE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
8554%
9020%
38%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF RAINBOW CHILDRENS MEDICARE



RAINBOW CHILDRENS MEDICARE vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF RAINBOW CHILDRENS MEDICARE

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0
0.06
0.1
0.05
0
0.07
0.1
0.06
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF RAINBOW CHILDRENS MEDICARE

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF RAINBOW CHILDRENS MEDICARE

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
0.99%
0.44%
-0.57%
-0.93%
9.65%
10.61%
8.23%
7.43%
QtrlyTrend
4
Latest Qtr: Dec2023
Quarterly Result Analysis →


RAINBOW CHILDRENS MEDICARE related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP -1.6% 8.4% 61.4%
S&P BSE 250 SMALLCAP -1.7% 8.8% 60.7%
S&P BSE MIDSMALLCAP -2.1% 6.3% 61.6%
S&P BSE 400 MIDSMALLCAP -2.3% 5.7% 56.5%
S&P BSE ALLCAP -2.5% 2.7% 37.3%
NSE Indices1W1M1Y
NIFTY SMALLCAP250 -1.4% 9.1% 66.6%
NIFTY MID SMALL400 -2.3% 6.2% 59.1%
NIFTY500 MULTICAP 50:25:25 -2.4% 3.9% 44.7%
NIFTY 500 -2.5% 2.4% 36.3%

You may also like the below Video Courses


FAQ about RAINBOW CHILDRENS MEDICARE


Is RAINBOW CHILDRENS MEDICARE good for long term investment?

As on Apr 19,2024, the Fundamentals of RAINBOW CHILDRENS MEDICARE look Strong and hence it may be good for long term investment! See Financial Performance of RAINBOW CHILDRENS MEDICARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is RAINBOW CHILDRENS MEDICARE UnderValued or OverValued?

As on Apr 19,2024, RAINBOW CHILDRENS MEDICARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of RAINBOW CHILDRENS MEDICARE ?

As on Apr 19,2024, the Intrinsic Value of RAINBOW CHILDRENS MEDICARE is Rs. 15.06 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 15.06
Fair Value [Median EV / Sales Model] : Rs. 14.29
Fair Value [Median Price / Sales Model] : Rs. 943.51
Estimated Median Fair Value of RAINBOW CHILDRENS MEDICARE : Rs. 15.06

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is RAINBOW CHILDRENS MEDICARE trading at a Premium or Discount?

As on Apr 19,2024, RAINBOW CHILDRENS MEDICARE is trading at a Premium of 8554% based on the estimates of Median Intrinsic Value!